Clinical Trials Directory

Trials / Terminated

TerminatedNCT05710393

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

Hidradenitis Suppurativa - a Mendelian Trait? Genetic Pedigree and Linkage Analysis

Status
Terminated
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to find a genetic link or family trait connecting persons with Hidradenitis Suppurativa (HS) to each other. As a result, discover the cause and perhaps treatment for Hidradenitis Suppurativa (HS).

Detailed description

Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease characterized by multiple abscesses located predominantly in areas such as armpit, genital, pelvic, and perineum. It is considered an orphan disease of unknown origin and no existing treatment with a population prevalence estimated between 1-4%. It develops in otherwise healthy patients after puberty and affects patients life-long. HS often requires multiple surgical procedures to drain large abscesses, or hospitalization to treat infected wounds, can lead to feelings of personal embarrassment and social stigmatization. Anecdotal evidence from affected families shows that HS often "runs in families" and may be inherited in a Mendelian fashion; however, no adequately powered study has been undertaken to investigate this hypothesis. This project aims to characterize the inheritance pattern of HS in families, and identify the genetic cause of this disease in those families with evidence for monogenic inheritance. Data collection includes blood sample analysis (DNA), medical history, and information pertaining to any known family history of HS, from which a familial pedigree can be generated. This 'family-based' genetic study design will include both affected and unaffected family members, ideally spanning several generations. Therefore, study patients will be asked to refer their immediate and extended (affected and unaffected) family members to this research study.

Conditions

Timeline

Start date
2019-09-17
Primary completion
2026-02-27
Completion
2026-02-27
First posted
2023-02-02
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05710393. Inclusion in this directory is not an endorsement.